Provided by Tiger Trade Technology Pte. Ltd.

Rezolute, Inc.

4.18
+0.11502.83%
Volume:1.34M
Turnover:5.63M
Market Cap:402.02M
PE:-5.19
High:4.35
Open:4.03
Low:3.97
Close:4.06
52wk High:11.46
52wk Low:1.07
Shares:96.29M
Float Shares:72.51M
Volume Ratio:1.89
T/O Rate:1.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8039
EPS(LYR):-0.9791
ROE:-81.73%
ROA:-48.74%
PB:3.44
PE(LYR):-4.26

Loading ...

Wedbush Adjusts Price Target on Rezolute to $6 From $5, Maintains Outperform Rating

MT Newswires Live
·
Jun 03

Rezolute Is Maintained at Buy by BTIG

Dow Jones
·
Jun 03

Rezolute upgraded to Outperform from Market Perform at Citizens

TIPRANKS
·
Jun 03

Rezolute price target raised to $6 from $5 at BTIG

TIPRANKS
·
Jun 03

Analysts Are Bullish on These Healthcare Stocks: Rezolute (RZLT), Relay Therapeutics (RLAY)

TIPRANKS
·
Jun 03

Rezolute price target raised to $14 from $10 at Maxim

TIPRANKS
·
Jun 03

Rezolute Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 02

BUZZ-U.S. STOCKS ON THE MOVE-Dollar General, Vera, Amtech Systems

Reuters
·
Jun 02

Rezolute Says 6 Participants Meet Responder Criterion in Phase 3 Tumor Hyperinsulinism Trial

MT Newswires Live
·
Jun 02

BUZZ-U.S. STOCKS ON THE MOVE-Microchip Technology, Marvell Technology, Generac

Reuters
·
Jun 02

BUZZ-Rezolute climbs after positive trial results for low blood sugar treatment

Reuters
·
Jun 02

Rezolute says 6 of 8 patients meet primary endpoint in Phase 3 upLIFT trial of ersodetug for tumor hyperinsulinism

Reuters
·
Jun 02

Rezolute - Topline Results for Uplift Study Expected in Second Half of 2026

THOMSON REUTERS
·
Jun 02

Rezolute - All 6 Responders Achieve Complete Discontinuation of Intravenous Glucose Requirements

THOMSON REUTERS
·
Jun 02

Rezolute - 6 of 8 Participants Meet Primary Endpoint Responder Criterion in Uplift Study

THOMSON REUTERS
·
Jun 02

Rezolute Announces Positive Interim Data for Its Phase 3 Uplift Study of Ersodetug in Tumor Hyperinsulinism

THOMSON REUTERS
·
Jun 02

Rezolute Is Maintained at Buy by Maxim Group

Dow Jones
·
May 15

Rezolute price target raised to $10 from $4 at Maxim

TIPRANKS
·
May 14

Maxim Group Keeps Their Buy Rating on Rezolute (RZLT)

TIPRANKS
·
May 14

High Growth Tech Stocks in US for May 2026

Simply Wall St.
·
May 14